CLINICAL_TRIALS
trial_result
· 2020-10-19
Clinical Trial Update: Trial Of PF-00299804 In Patients With Advanced Refractory Lung Cancer [Phase 2]
Summary
Phase 2 trial of PF-00299804 in patients with advanced refractory non-small cell lung carcinoma completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Carcinoma, Non Small Cell Lung | Phase 2 | Status: COMPLETED | Results posted: 2020-10-19